Contact us via E-Mail
Follow us on LinkedInAll-time Popular Posts
A biobetter trastuzumab is on the way 
EGA president calls on Member States to boost market access for biosimilars in the EU 
3rd Forum on Biosimilars 
Pfizer starts biosimilar rituximab Phase I/II trial 
Indian Biosimilars Market 
World’s first biosimilar antibody* is approved in Korea 
A biosimilar manufacturer: Celltrion 
2 patents down, 1 to expire: Herceptin biosimilar coming to EU
